Product Overview

This product is a pharmaceutical intermediate primarily used in the synthesis of nucleoside analogues and complex organic molecules, participating as a key structural unit in multi-step reactions. Its chemical structure comprises a cyclopentanoyl-1,3-dioxanones skeleton combined with an L-tartrate salt, exhibiting excellent reactivity and stability. It is suitable for various stages, including drug development, small-scale preparation, pilot-scale amplification, and commercial production. It is widely used in the development of synthetic pathways for innovative drugs such as antiviral and antitumor drugs, meeting customers' needs for high purity, high stability, and scalability.

Applications

• Intermediates for nucleoside analogue synthesis
• Antiviral drug process development
• Construction of peptides and complex organic molecules
• Preparation of drug impurity standards
• Customized pharmaceutical synthesis services

Quality & Supply Capability

English Name: 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid Properties: This product is a white to off-white solid with a stable cyclopentano-1,3-dioxonol structure containing amino and hydroxyl functional groups. It is readily soluble in polar organic solvents, exhibits good thermal stability, and is suitable for various organic synthesis reaction systems. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the specific COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging Documentation Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from laboratory sample supply to small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust purity grades, impurity control standards, packaging specifications, and delivery cycles according to customer needs, with complete quality documentation support. Meanwhile, we provide comprehensive technical support from the early stages of R&D to industrial production, assisting customers in optimizing synthesis routes, improving process efficiency, and promoting the smooth transformation and implementation of projects.

Why Choose Bioncan

Focus on pharmaceutical intermediates, with in-depth expertise in nucleoside and complex compound synthesis technologies. Full-scale supply capabilities, covering needs from laboratory to commercial production. Provide complete quality control documentation to ensure product compliance with ICH and GMP standards. Support customized needs, adjusting purity, impurity control, and packaging solutions according to customer requirements. Provide supporting process optimization technologies to help customers develop efficient and economical synthetic routes. Offer scale-up support services to ensure a seamless transition from laboratory to production line.

Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 376608-65-0, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.